The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and development, according to a new RAND study.
Modular nanoparticles developed for targeted drug delivery and neutralizing biological agents
Engineers at the University of California San Diego have developed modular nanoparticles that can be easily customized to target different biological entities such as tumors,